53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
At CHEST 2025, held in Chicago, Illinois, Laurie Slovarp, PhD, CCC-SLP, professor at the University of Montana and certified speech pathologist, presented a poster on the development of a digital therapeutic designed to improve access to behavioral cough suppression therapy for patients with refractory chronic cough.
A large-scale trial examining the effect of azithromycin on the relationship between oesophageal function and cough as evaluated by Hyfe's cough monitoring technology in respiratory disease is feasible and acceptable to patients.
This study used Hyfe's wearable cough monitor during a 7-day run in, 28-day treatment, and 14-day follow-up period in patients with chronic bronchitis.
Periods of intense coughing (termed bouts, epochs or bursts) are particularly problematic for some coughers and may not be reflected by simply counting the number of coughs per day. This study explored how varying the definition of bouts yield different impressions of cough severity.
09.01.2023
This multi-site study investigates the potential of digital cough sounds as predictive biomarkers for clinical outcomes in hospitalized COVID-19 patients. It aims to determine if the acoustic properties of coughs can predict the severity and progression of the disease.
Methodology: The authors utilized digital cough recordings from hospitalized COVID-19 patients using Hyfe's cough detection and monitoring platform. Advanced acoustic analysis techniques were applied to these recordings to identify specific characteristics or patterns associated with different clinical outcomes.
Key Findings:
Implications for Healthcare:
The study concludes that digital cough monitoring holds promise as a non-invasive, efficient, and effective way to predict clinical outcomes in COVID-19 patients. This innovative approach could enhance patient management and treatment strategies in the ongoing fight against COVID-19.
